5-bromo-2'-deoxyuridine blocks myogenesis by extinguishing expression of MyoD1.

The pyrimidine analog 5-bromodeoxyuridine (BUdR) competes with thymidine for incorporation into DNA. Substitution of BUdR for thymidine does not significantly affect cell viability but does block cell differentiation in many different lineages. BUdR substitution in a mouse myoblast line blocked myogenic differentiation and extinguished the expression of the myogenic determination gene MyoD1. Forced expression of MyoD1 from a transfected expression vector in a BUdR-substituted myoblast overcame the block to differentiation imposed by BUdR. Activation of BUdR-substituted muscle structural genes and apparently normal differentiation were observed in transfected myoblasts. This shows that BUdR blocks myogenesis at the level of a myogenic regulatory gene, possibly MyoD1, not by directly inhibiting the activation of muscle structural genes. It is consistent with the idea that BUdR selectively blocks a class of regulatory genes, each member of which is important for the development of a different cell lineage.

[1]  C. Auffray,et al.  Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. , 2005, European journal of biochemistry.

[2]  Victor K. Lin,et al.  Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD , 1989, Cell.

[3]  R. Umek,et al.  New beginnings in studies of eukaryotic DNA replication origins. , 1989, Biochimica et biophysica acta.

[4]  W. McGinnis,et al.  Autoregulation of a drosophila homeotic selector gene , 1988, Cell.

[5]  S. Tapscott,et al.  MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts. , 1988, Science.

[6]  M. Bienz,et al.  Domain of Ultrabithorax expression in Drosophila visceral mesoderm from autoregulation and exclusion , 1988, Nature.

[7]  M. DePamphilis,et al.  Is c-myc protein directly involved in DNA replication? , 1988, Science.

[8]  H. Weintraub,et al.  Expression of a single transfected cDNA converts fibroblasts to myoblasts , 1987, Cell.

[9]  F. Dean,et al.  Simian virus 40 large tumor antigen requires three core replication origin domains for DNA unwinding and replication in vitro. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Walter J. Gehring,et al.  Regulation and function of the Drosophila segmentation gene fushi tarazu , 1987, Cell.

[11]  Harold Weintraub,et al.  Transfection of a DNA locus that mediates the conversion of 10T1 2 fibroblasts to myoblasts , 1986, Cell.

[12]  S. Riva,et al.  Fate of exogenous recombinant plasmids introduced into mouse and human cells. , 1985, Nucleic acids research.

[13]  L. Lukens,et al.  Changes in the Nuclear and Cytoplasmic Levels of Type I and Type II Collagen RNAs during Growth of Chondrocytes in 5‐Bromo‐2′‐Deoxyuridine , 1985, The Journal of biological chemistry.

[14]  S. F. Konieczny,et al.  5-azacytidine induction of stable mesodermal stem cell lineages from 10T1/2 cells: Evidence for regulatory genes controlling determination , 1984, Cell.

[15]  W. Wright,et al.  Regulation of rat myosin light-chain synthesis in heterokaryons between 5-bromodeoxyuridine-blocked rat myoblasts and differentiated chick myocytes , 1983, The Journal of cell biology.

[16]  D. Fischman,et al.  Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro , 1982, The Journal of cell biology.

[17]  W. Wright.  The BrdU content of DNA is decreased during reversal of inhibition of myogenesis by deoxycytidine , 1982, Somatic cell genetics.

[18]  Peter A. Jones,et al.  Changes in phenotypic expression in embryonic and adult cells treated with 5‐azacytidine , 1982, Journal of cellular physiology.

[19]  Peter A. Jones,et al.  Cellular differentiation, cytidine analogs and DNA methylation , 1980, Cell.

[20]  R. Davidson,et al.  Inhibition of friend erythroleukemic cell differentiation by bromodeoxyuridine: Correlation with the amount of bromodeoxyuridine in dna , 1980, Journal of cellular physiology.

[21]  Peter A. Jones,et al.  Multiple new phenotypes induced in 10T 1 2 and 3T3 cells treated with 5-azacytidine , 1979, Cell.

[22]  G. Bennett,et al.  Selective binding of antibody against gizzard 10-nm filaments to different cell types in myogenic cultures. , 1978, The American journal of anatomy.

[23]  M. O'Neill,et al.  5-Bromodeoxyuridine inhibition of differentiation. Kinetics of inhibition and reversal in myoblasts. , 1974, Developmental biology.

[24]  H. Weintraub,et al.  Identification of a developmental program using bromodeoxyuridine. , 1972, Journal of molecular biology.

[25]  A. Riggs,et al.  Lac operator analogues: bromodeoxyuridine substitution in the lac operator affects the rate of dissociation of the lac repressor. , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J. R. Coleman,et al.  The reversible control of animal cell differentiation by the thymidine analog, 5-bromodeoxyuridine. , 1970, Experimental cell research.

[27]  H. Holtzer,et al.  INHIBITION OF MYOBLAST FUSION AFTER ONE ROUND OF DNA SYNTHESIS IN 5-BROMODEOXYURIDINE , 1970, The Journal of cell biology.

[28]  J. Abbott,et al.  The loss of phenotypic traits by differentiated cells, V. The effect of 5-bromodeoxyuridine on cloned chondrocytes. , 1968, Proceedings of the National Academy of Sciences of the United States of America.

[29]  K. Okazaki,et al.  5-Bromodeoxyuridine: Effect on Myogenesis in vitro , 1964, Science.

[30]  W. Rutter,et al.  Toward molecular mechanisms of developmental processes. , 1973, Annual review of biochemistry.